Correction to: BMC Infect Dis (2021) 21:857 https://doi.org/10.1186/s12879-021-06544-3
Following publication of the original article [1], the authors identified an error in the author name of Lynda Abicher.
The incorrect author name is: Linda Abicher.
The correct author name is: Lynda Abicher.
The original article [1] has been corrected.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Louis Bont, Email: l.bont@umcutrecht.nl.
The RSV GOLD III—ICU Network Study Group:
Maria Ahuoiza Garba, Fatima Jumai Giwa, Mohammad Hafiz Rasooly, Aminullah Shirpoor, Merwais Azizyar, Lamin Makalo, Ousman Nyan, Ali Mohamed, Khalid Osman, Ram Hari Chapagain, Krishna Prasad Bista, Arun Kumar Sharma, Prabina Shrestha, Bamenla Goka, Kwabena Osman, Evangeline Obodai, Henshaw Mandi, Lucas Esuh Esong, Charlotte Ekoube Eposse, Valéria Muando, Tufária Mussá, Yasser Habresh Said, Aika Abia Shoo, Vanessa Jaelle Dor, Jacqueline Gautier, and Lynda Abicher
Reference
- 1.Löwensteyn YN, Mazur NI, Nair H, Willemsen JE, van Thiel G, Bont L, on behalf of the RSV GOLD III—ICU Network Study Group Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol. BMC Infect Dis. 2021;21:857. doi: 10.1186/s12879-021-06544-3. [DOI] [PMC free article] [PubMed] [Google Scholar]